BRPI1015311A2 - método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada - Google Patents

método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada

Info

Publication number
BRPI1015311A2
BRPI1015311A2 BRPI1015311A BRPI1015311A BRPI1015311A2 BR PI1015311 A2 BRPI1015311 A2 BR PI1015311A2 BR PI1015311 A BRPI1015311 A BR PI1015311A BR PI1015311 A BRPI1015311 A BR PI1015311A BR PI1015311 A2 BRPI1015311 A2 BR PI1015311A2
Authority
BR
Brazil
Prior art keywords
processed
neurotoxin polypeptide
kit
determining
solution containing
Prior art date
Application number
BRPI1015311A
Other languages
English (en)
Inventor
Josef Friedrich
Michael Pfeil
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of BRPI1015311A2 publication Critical patent/BRPI1015311A2/pt
Publication of BRPI1015311B1 publication Critical patent/BRPI1015311B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI1015311-0A 2009-04-27 2010-04-23 Método para determinar a quantidade de polipeptídeo de neurotoxina processada em uma solução, dispositivo para determinação da quantidade de polipeptídeo de neurotoxina processada contida em uma solução e kit adaptado BRPI1015311B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21465009P 2009-04-27 2009-04-27
EP09158788 2009-04-27
US61/214,650 2009-04-27
EP09158788.1 2009-04-27
PCT/EP2010/055432 WO2010124998A1 (en) 2009-04-27 2010-04-23 Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities

Publications (2)

Publication Number Publication Date
BRPI1015311A2 true BRPI1015311A2 (pt) 2016-04-19
BRPI1015311B1 BRPI1015311B1 (pt) 2024-01-09

Family

ID=41066304

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015311-0A BRPI1015311B1 (pt) 2009-04-27 2010-04-23 Método para determinar a quantidade de polipeptídeo de neurotoxina processada em uma solução, dispositivo para determinação da quantidade de polipeptídeo de neurotoxina processada contida em uma solução e kit adaptado

Country Status (14)

Country Link
US (2) US8663942B2 (pt)
EP (1) EP2425251B1 (pt)
JP (1) JP5689113B2 (pt)
KR (1) KR101818777B1 (pt)
CN (1) CN102414564B (pt)
AU (1) AU2010243692B2 (pt)
BR (1) BRPI1015311B1 (pt)
CA (1) CA2757637C (pt)
ES (1) ES2647243T3 (pt)
IL (1) IL215441A (pt)
MX (1) MX2011011045A (pt)
PT (1) PT2425251T (pt)
RU (1) RU2545783C9 (pt)
WO (1) WO2010124998A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012020057A1 (en) * 2010-08-11 2012-02-16 Merz Pharma Gmbh & Co. Kgaa Selective manufacture of recombinant neurotoxin polypeptides
WO2014079495A1 (en) 2012-11-21 2014-05-30 Syntaxin Limited Methods for the manufacture of proteolytically processed polypeptides
AU2014301116B2 (en) * 2013-06-28 2019-11-14 Merz Pharma Gmbh & Co. Kgaa Means and methods for the determination of the biological activity of Neurotoxin polypeptides in cells
KR102409293B1 (ko) 2014-11-21 2022-06-14 메르츠 파마 게엠베하 운트 코. 카가아 신경독소 폴리펩티드의 생물학적 활성의 측정 방법
RU2694964C2 (ru) * 2017-12-19 2019-07-19 ФЕДЕРАЛЬНОЕ АГЕНТСТВО ПО ТЕХНИЧЕСКОМУ РЕГУЛИРОВАНИЮ И МЕТРОЛОГИИ (Росстандарт) Способ измерений каталитической активности (каталитической концентрации) ферментов с использованием методов масс-спектрометрии и спектрофотометрии с предварительной идентификацией целевого аналита и определением чистоты веществ
CN119291194A (zh) 2018-01-12 2025-01-10 建新公司 用于定量多肽的方法
WO2020024002A1 (en) * 2018-07-31 2020-02-06 Snoretox Pty Ltd Pegylated tetanus neurotoxins and treatment of hypotonia
EP3946413A4 (en) * 2019-04-03 2023-01-11 Technical University of Denmark NEUROTROPHIC FACTOR PROTEIN CONJUGATES AND RELATED EMBODIMENTS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
JPH05501351A (ja) * 1989-08-16 1993-03-18 カイロン　コーポレイション プロホルモンタンパク質に対する開裂部位阻止抗体及びその使用
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
ATE348178T1 (de) * 1999-08-25 2007-01-15 Allergan Inc Aktivierbare rekombinante neurotoxine
US6678651B2 (en) * 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
WO2005076785A2 (en) * 2003-12-19 2005-08-25 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
RU2009149604A (ru) * 2007-06-01 2011-07-20 Мерц Фарма Гмбх Унд Ко. Кгаа (De) Способ предоставления устойчивого к температуре миорелаксанта на основе нейротоксичного компонента ботулинического токсина в твердой форме
US7732579B2 (en) * 2007-06-13 2010-06-08 The United States Of America As Represented By The Secretary Of Agriculture High-affinity monoclonal antibodies for botulinum toxin type A
US8486422B2 (en) * 2007-07-26 2013-07-16 Allergan, Inc. Methods of activating clostridial toxins
CN101386648B (zh) * 2008-09-25 2012-05-30 中国人民解放军军事医学科学院微生物流行病研究所 抗b型肉毒神经毒素中和性单克隆抗体、其制备方法及用途
CA2751311C (en) * 2009-02-19 2019-08-06 Merz Pharma Gmbh & Co. Kgaa Means and methods for manufacturing highly pure neurotoxin

Also Published As

Publication number Publication date
JP5689113B2 (ja) 2015-03-25
RU2011147994A (ru) 2013-06-10
KR101818777B1 (ko) 2018-01-15
EP2425251A1 (en) 2012-03-07
ES2647243T3 (es) 2017-12-20
US20120142024A1 (en) 2012-06-07
PT2425251T (pt) 2017-11-27
KR20120005041A (ko) 2012-01-13
US8663942B2 (en) 2014-03-04
IL215441A0 (en) 2011-12-29
CN102414564B (zh) 2015-01-21
RU2545783C2 (ru) 2015-04-10
MX2011011045A (es) 2011-11-04
CN102414564A (zh) 2012-04-11
HK1169171A1 (en) 2013-01-18
CA2757637A1 (en) 2010-11-04
EP2425251B1 (en) 2017-10-25
US20140134643A1 (en) 2014-05-15
IL215441A (en) 2015-04-30
CA2757637C (en) 2017-10-24
AU2010243692A1 (en) 2011-10-27
BRPI1015311B1 (pt) 2024-01-09
JP2012525563A (ja) 2012-10-22
RU2545783C9 (ru) 2016-02-27
AU2010243692B2 (en) 2015-03-05
WO2010124998A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
BR112012029897A2 (pt) método para reduzir a quantidade de uma serina protease ou um zimogênio de serina protease em uma composição, método para preparar uma composição, composição de proteína derivada de plasma, e, método para tratamento de uma doença
BRPI1015311A2 (pt) método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada
PL2358756T3 (pl) Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9
BRPI1011886A2 (pt) solução contendo ácido hiplocloroso e métodos do uso do mesmo.
IL243157B (en) Means and methods for determining the biological activity of neurotoxin polypeptides in cells
BRPI1015026A2 (pt) método e aparelho para facilitar os procedimentos de medição em operação de multiportadora.
FI20115893L (fi) Menetelmä retention säätämiseksi ja menetelmässä käytettävä välituote
BRPI0914824A2 (pt) produção de proteína melhorada e armazenagem em plantas
EE200900072A (et) Territooriumi ja selle perimeetri jälgimise süsteem ja meetod
BR112014010162A2 (pt) uso de composição, método para melhorar o reconhecimento e/ou tratar ou prevenir função de reconhecimento prejudicada em um indivíduo, e composição
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BR112012002137A2 (pt) método para um polipeptídeo e/ou vírus de interesse em uma cultura de célula contínua,e, composição
BR112013015527A2 (pt) implante crestal e método para o seu processamento
BRPI0923290A2 (pt) métodos para remover acrilamida em uma massa aquosa de fluido, e para remover acrilamida em um fluido aquoso de tratamento de poço, e, composição aquosa de fluido para tratamento de poço.
FI20085409L (fi) Menetelmä ja laite viestien käsittelemiseksi
BRPI1013965A2 (pt) sistema de moagem e método de moagem.
EP2527671A4 (en) TORQUE COMPENSATION PROCEDURE FOR A FOUR-POINT CONTACT BALL BEARING AND CALCULATION DEVICE AND CALCULATION PROGRAM THEREFOR
BRPI1013361A2 (pt) método para evitar e tratar hipermeabilidade.
BR112013015453A2 (pt) composição não-espumante e método para o tratamento não-terapêutico das matérias queratínicas
BR112012005140A2 (pt) inibidores de hsl úteis no tratamento de diabetes
BRPI1014960A2 (pt) sistema para uso em uma aplicação de poço submarino, e método
BR112014000219A2 (pt) dispositivo de ensaio para a detecção de uma enzima ativa em uma amostra, método de determinação de presença e dos níveis de uma enzima ativa em uma amostra, kit, dispositivo de ensaio, ou método de uso ou o uso do mesmo e uso
BRPI0914933A2 (pt) Composições e métodos para níveis de aminoácido aumentados em plantas
GB2502761B (en) Method and internal control composition for determining the efficacy of enzymatic cell lysis

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.